The Effect of PERT on Patients Undergoing Pancreaticoduodenectomy
Phase 4
Recruiting
- Conditions
- Pancreatic Exocrine InsufficiencyPancreaticoduodenectomyPancreatic Enzyme Replacement Therapy
- Interventions
- Other: Routine treatment plan
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06119880
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
Phase 2
Recruiting
- Conditions
- Osteosarcoma
- Interventions
- Combination Product: metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
- First Posted Date
- 2023-11-02
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 43
- Registration Number
- NCT06114225
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China
A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Gynecological Surgeries(SPiM-RWS-GYN)
Recruiting
- Conditions
- Gynecological Surgeries
- Interventions
- Device: da Vinci SP Surgical System
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT06082011
- Locations
- 🇨🇳
Shanghai JiaoTong University School of Medicine affliated Ruijin Hospital, Shanghai, Shanghai, China
A Clinical Validation Study to Evaluate the Diagnostic Accuracy of a Cough-based Auxiliary Diagnosis Algorithm for COPD
Recruiting
- Conditions
- COPDCoughAlgorithm
- First Posted Date
- 2023-10-13
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06082791
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Remote Programming for Deep Brain Stimulation in Parkinson's Disease.
Not Applicable
Recruiting
- Conditions
- Deep Brain StimulationParkinson Disease
- Interventions
- Device: standard programmingDevice: remote programming
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06078397
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Phase 2
Recruiting
- Conditions
- SarcomaSarcoma,Soft TissueSarcoma of Bone
- Interventions
- Combination Product: Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT06074692
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
Not Applicable
Recruiting
- Conditions
- NK-T-Cell Lymphoma, Extranodal
- Interventions
- Drug: 4 cycles of ESA regimen with sandwiched radiotherapy
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 89
- Registration Number
- NCT06069830
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
Phase 2
Not yet recruiting
- Conditions
- Relapsed or Refractory B-cell Lymphoma
- Interventions
- Drug: SR-GDP
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06062641
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanhai, China
TCR-T Cells in the Treatment of Advanced Pancreatic Cancer
Early Phase 1
Recruiting
- Conditions
- Pancreatic Cancer
- Interventions
- Drug: TCR-T Cells Injection（GB3010 Cells Injection）
- First Posted Date
- 2023-09-26
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT06054984
- Locations
- 🇨🇳
Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, ShangHai, Shanghai, China
COronary CoLLateralization in Type 2 diabEtic Patients With Chronic Total Occlusion
Recruiting
- Conditions
- Chronic Total Occlusion of Coronary ArteryDiabetes Mellitus, Type 2
- Interventions
- Other: Echocardiography
- First Posted Date
- 2023-09-26
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT06054126
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath